Pappas Ventures investor login | Search for: Home About About Us Our Strategy Our Focus Our News Events Portfolio Team For Entrepreneurs For Entrepreneurs Submit a Business Plan Contact Us Pappas-founded CoLucid Pharmaceuticals announces achievement of both primary and key secondary endpoints in Phase 3 pivotal trial of lasmiditan in migraine. 9.6.2016 learn more » FEATURE finding opportunities, cultivating innovation, and advancing patient care. learn more » TEAM leveraging in-depth knowledge and a history of success in life sciences. learn more » FOCUS guiding innovative life science companies along the path to success. learn more » PORTFOLIO targeting biotech centers and tapping into emerging markets. learn more » STRATEGY Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Our entire team works closely with our portfolio companies and investors to deliver superior results for everyone involved. see why our singular focus is our strength » An expert team dedicated to success. click here » A portfolio of innovative companies. click here » Home Contact Us Investor Login About Our Strategy Our Focus Our News Events Portfolio Team For Entrepreneurs Submit a Business Plan follow us on twitter linkedin Pappas Ventures ©2013 Pappas Ventures 2520 Meridian Parkway, Suite 400 Durham, NC 27713 T: 919-998-3300 F: 919-998-3301 Design by REVERED